|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-3-6
|
|
pubmed:abstractText |
An effective and well tolerated intravenous (IV) bisphosphonate could provide a new treatment method for patients with osteoporosis. The Dosing IntraVenous Administration (DIVA) study was designed to identify the optimal ibandronate IV injection schedule for the treatment of postmenopausal osteoporosis by comparing the efficacy and tolerability of 2- and 3-monthly injections with the previously evaluated daily oral ibandronate regimen. We report the effects on lumbar spine and proximal femur bone mineral density (BMD) and bone resorption markers over 2 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:AdamiSilvanoS,
pubmed-author:CivitelliRobertoR,
pubmed-author:CzerwinskiEdwardE,
pubmed-author:DelmasPierre DPD,
pubmed-author:EismanJohn AJA,
pubmed-author:FelsenbergDieterD,
pubmed-author:HughesClaireC,
pubmed-author:MaironNicoleN,
pubmed-author:MasanauskaiteDaivaD,
pubmed-author:PrinceRichardR,
pubmed-author:ReckerRobert RRR,
pubmed-author:RecknorChrisC,
pubmed-author:ReginsterJean-YvesJY,
pubmed-author:ReidDavid MDM,
pubmed-author:ZaidiMoneM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
488-97
|
|
pubmed:meshHeading |
pubmed-meshheading:18260172-Administration, Oral,
pubmed-meshheading:18260172-Aged,
pubmed-meshheading:18260172-Bone Density,
pubmed-meshheading:18260172-Bone Density Conservation Agents,
pubmed-meshheading:18260172-Diphosphonates,
pubmed-meshheading:18260172-Dose-Response Relationship, Drug,
pubmed-meshheading:18260172-Drug Administration Schedule,
pubmed-meshheading:18260172-Female,
pubmed-meshheading:18260172-Humans,
pubmed-meshheading:18260172-Infusions, Intravenous,
pubmed-meshheading:18260172-Lumbar Vertebrae,
pubmed-meshheading:18260172-Middle Aged,
pubmed-meshheading:18260172-Osteoporosis, Postmenopausal
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
|
|
pubmed:affiliation |
Garvan Institute of Medical Research, St. Vincent's Campus and University of New South Wales, Sydney, Australia. j.eisman@garvan.org.au
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
